Join
Live feed
·
INSIDERFilingvia Quantisnow
Regulus Therapeutics Inc. logo

Director Papadopoulos Stelios returned 64,635 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RGLS· Regulus Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RGLS (Regulus Therapeutics Inc.) and more on Quantisnow.